z-logo
open-access-imgOpen Access
Continuous Propagation of Radiation Leukemia Virus on a C57BL Mouse-Embryo Fibroblast Line, with Attenuation of Leukemogenic Activity
Author(s) -
M Lieberman,
Ohtsura Niwa,
A. Declève,
Henry S. Kaplan
Publication year - 1973
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.70.4.1250
Subject(s) - biology , virus , virology , embryo , cell culture , in vitro , serial passage , murine leukemia virus , microbiology and biotechnology , leukemia , rickettsia , immunofluorescence , fibrosarcoma , antibody , immunology , biochemistry , genetics
The radiation leukemia virus (RadLV), a murine leukemia virus derived from thymic lymphomas induced by x-irradiation in strain C57BL/Ka mice, has been successfully propagated in sustained high titerin vitro in a newly established line, BL-5, of C57BL/Ka mouse-embryo fibroblasts. In addition, the production of endogenous virus, presumed to be RadLV, has been induced and sustained through multiple serial passages after treatment of BL-5 cell cultures with 5-bromodeoxyuridine. The chronically RadLV-infected subline, designated BL-5 (RadLV), sheds virus into the supernatant culture fluids that is biologically activein vitro in the XC cell plaque assay, in interference assays for focus-formation by murine sarcoma virus, and in the intracellular induction of group-specific antigens detectable by immunofluorescence, but is apparently devoid of leukemogenic activity after intrathymic inoculation into neonatal or immunosuppressed C57BL/Ka mice. Although BL-5 cells exhibited morphological alterations suggestive of transformationin vitro and gave rise to fibrosarcomatous ascites tumors after intraperitoneal inoculation with C57BL/Ka mice, the chronically infected BL-5(RadLV) cells remained normal in morphology and failed to yield fibrosarcomasin vivo .

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here